A detailed history of Globeflex Capital L P transactions in Abbott Laboratories stock. As of the latest transaction made, Globeflex Capital L P holds 6,721 shares of ABT stock, worth $766,261. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,721
Previous 6,721 -0.0%
Holding current value
$766,261
Previous $763,000 8.52%
% of portfolio
0.07%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $46,339 - $56,009
-454 Reduced 6.33%
6,721 $730,000
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $828,927 - $1.01 Million
7,175 New
7,175 $1.01 Million
Q2 2021

Aug 12, 2021

SELL
$105.79 - $124.53 $417,976 - $492,018
-3,951 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $427,850 - $504,072
3,931 Added 19655.0%
3,951 $473,000
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $1,457 - $1,700
20 New
20 $2,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.